Export 114 results:
Author Title Type [ Year(Desc)]
Filters: Author is Saraiva, M.J.  [Clear All Filters]
2010
Macedo, B., Magalhães, J., Batista, A. R., & Saraiva, M. J. (2010). Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacological Research, 62(6), 514 - 522.
Saraiva, A. M., Cardoso, I., Pereira, M. C., Coelho, M. A. N., et al. (2010). Controlling amyloid-β peptide(1-42) oligomerization and toxicity by fluorinated nanoparticles. ChemBioChem, 11(13), 1905 - 1913.
Santos, S. D., Lambertsen, K. L., Clausen, B. H., Akinc, A., et al. (2010). CSF transthyretin neuroprotection in a mouse model of brain ischemia. Journal of Neurochemistry, 115(6), 1434 - 1444.
Santos, S. D., Fernandes, R., & Saraiva, M. J. (2010). The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems. Neurobiology of Aging, 31(2), 280 - 289.
Martinho, A., Gonçalves, I., Cardoso, I., Almeida, M. R., et al. (2010). Human metallothioneins 2 and 3 differentially affect amyloid-beta binding by transthyretin. FEBS Journal, 277(16), 3427 - 3436.
Saraiva, A. M., Cardoso, I., Saraiva, M. J., Tauer, K., et al. (2010). Randomization of Amyloid-β-Peptide(1-42) Conformation by Sulfonated and Sulfated Nanoparticles Reduces Aggregation and Cytotoxicity. Macromolecular Bioscience, 10(10), 1152 - 1163.
Cardoso, I., Martins, D., Ribeiro, T., Merlini, G., & Saraiva, M. J. (2010). Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: Studies in FAP mouse models. Journal of Translational Medicine, 8.
Magalhães, J., Santos, S. D., & Saraiva, M. J. (2010). αB-crystallin (HspB5) in familial amyloidotic polyneuropathy. International Journal of Experimental Pathology, 91(6), 515 - 521.
2011
Magalhães, J., & Saraiva, M. J. (2011). Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy. Journal of Neuropathology and Experimental Neurology, 70(12), 1097 - 1106.
Oliveira, S. M., Ribeiro, C. A., Cardoso, I., & Saraiva, M. J. (2011). Gender-dependent transthyretin modulation of brain amyloid-β Levels: Evidence from a mouse model of alzheimer's disease. Journal of Alzheimer's Disease, 27(2), 429 - 439.
Noborna, F., O'Callaghan, P., Hermansson, E., Zhang, X., et al. (2011). Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein. Proceedings of the National Academy of Sciences of the United States of America, 108(14), 5584 - 5589.
Ferreira, N., Saraiva, M. J., & Almeida, M. R. (2011). Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Letters, 585(15), 2424 - 2430.
Quintela, T., Gonçalves, I., Martinho, A., Alves, C. H., et al. (2011). Progesterone enhances transthyretin expression in the rat choroid plexus in vitro and in vivo via progesterone receptor. Journal of Molecular Neuroscience, 44(3), 152 - 158.
Sárkány, Z., Ikonen, T. P., Ferreira-Da-Silva, F., Saraiva, M. J., et al. (2011). Solution structure of the soluble receptor for advanced glycation end products (sRAGE). Journal of Biological Chemistry, 286(43), 37525 - 37534.
Castro-Rodrigues, A. F., Gales, L., Saraiva, M. J., & Damas, A. M. (2011). Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils. Acta Crystallographica Section D: Biological Crystallography, 67(12), 1035 - 1044.
Pires, R. H., Saraiva, M. J., Damas, A. M., & Kellermayer, M. S. Z. (2011). Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy. Journal of Molecular Recognition, 24(3), 467 - 476.
Niederhauser, J., Lobrinus, J. A., Ochsner, F., Wider, C., et al. (2011). Successful heart and liver transplantation in a swiss patient with glu89lys transthyretin amyloidosis. Transplantation, 91(6), e40 - e42.
2012
Almeida, M. R., & Saraiva, M. J. (2012). Clearance of extracellular misfolded proteins in systemic amyloidosis: Experience with transthyretin. FEBS Letters, 586(18), 2891 - 2896.
Pires, R. H., Karsai, Á., Saraiva, M. J., Damas, A. M., & Kellermayer, M. S. Z. (2012). Distinct Annular Oligomers Captured along the Assembly and Disassembly Pathways of Transthyretin Amyloid Protofibrils. PLoS ONE, 7(9).
Obici, L., Cortese, A., Lozza, A., Lucchetti, J., et al. (2012). Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: A phase II study. Amyloid, 19(SUPPL. 1), 34 - 36.
Ferreira, N., Saraiva, M. J., & Almeida, M. R. (2012). Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "In vivo" evidence from FAP mice models. PLoS ONE, 7(1).
Magalhães, J., & Saraiva, M. J. (2012). The heat shock response in FAP: The role of the extracellular chaperone clusterin. Amyloid, 19(SUPPL. 1), 3 - 4.
Ferreira, N., Saraiva, M. J., & Almeida, M. R. (2012). Natural polyphenols as modulators of TTR amyloidogenesis: In vitro and in vivo evidences towards therapy. Amyloid, 19(SUPPL. 1), 39 - 42.
Gonçalves, N. P., Oliveira, H., Pêgo, A. P., & Saraiva, M. J. (2012). A novel nanoparticle delivery system for in vivo targeting of the sciatic nerve: Impact on regeneration. Nanomedicine, 7(8), 1167 - 1180.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc